Why is Vaishali Pharma falling/rising?

As of 30-Sep, Vaishali Pharma Ltd's stock price is currently at 11.31, reflecting a decrease of 0.19, or 1.65%. The stock has underperformed its sector by 1.44% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has declined by 5.51%, and it has seen a significant drop of 35.33% year-to-date. The company's delivery volume has also fallen sharply, with a 46.68% decrease compared to the 5-day average, indicating reduced investor participation. Additionally, the company has reported weak long-term fundamentals, including a staggering -145.73% CAGR growth in operating profits over the last five years and a negative EBITDA, which contributes to the stock's recent decline.
In the broader market context, while the Sensex has experienced a slight decline of 2.22% over the past week, Vaishali Pharma's performance has been significantly worse, highlighting its struggles. The stock has underperformed the market over the last year, with a return of -41.30% compared to the BSE500's -6.58%. This stark contrast underscores the company's challenges, including a poor ability to service its debt and low profitability per unit of shareholders' funds, which further diminishes investor confidence and contributes to the stock's downward trajectory.